4//SEC Filing
TRV GP IV, LLC 4
Accession 0001193125-25-199177
CIK 0001819133other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:15 PM ET
Size
10.6 KB
Accession
0001193125-25-199177
Insider Transaction Report
Form 4
TRV GP IV, LLC
10% Owner
Transactions
- Sale
Common Stock
2025-09-05$7.00/sh−642,906$4,500,342→ 14,813,975 total - Sale
Common Stock
2025-09-08$7.04/sh−86,459$608,628→ 14,727,516 total
Third Rock Ventures IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-09-05$7.00/sh−642,906$4,500,342→ 14,813,975 total - Sale
Common Stock
2025-09-08$7.04/sh−86,459$608,628→ 14,727,516 total
Third Rock Ventures GP IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-09-08$7.04/sh−86,459$608,628→ 14,727,516 total - Sale
Common Stock
2025-09-05$7.00/sh−642,906$4,500,342→ 14,813,975 total
Footnotes (2)
- [F1]These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001688325
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:15 PM ET
- Size
- 10.6 KB